Liping Chen

251 East Baizhang Road
Ningbo, 315040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Leukemia inhibitory factor drives malignant progression in lung squamous cell carcinoma via the PI3K/AKT/GSK-3β/β-catenin axis.

Leukemia inhibitory factor drives malignant progression in lung squamous cell carcinoma via the PI3K/AKT/GSK-3β/β-catenin axis.

Journal: Journal of molecular histology

Published: March 09, 2026

Research on the protection and restoration technology of glazed components in ancient architecture.

Research on the protection and restoration technology of glazed components in ancient architecture.

Journal: PloS one

Published: November 29, 2025

Emerging role of the TCA cycle and its metabolites in lung disease.

Emerging role of the TCA cycle and its metabolites in lung disease.

Journal: Frontiers in physiology

Published: April 30, 2025

CircFOXK2 induces non-small cell lung cancer tumorigenesis through the miR-328-5p/PKP3 axis.

CircFOXK2 induces non-small cell lung cancer tumorigenesis through the miR-328-5p/PKP3 axis.

Journal: Cellular and molecular biology (Noisy-le-Grand, France)

Published: April 23, 2025

Interleukin-17A Promotes Airway Remodeling in Chronic Obstructive Pulmonary Disease by Activating C-X-C Motif Chemokine Ligand 12 Secreted by Lung Fibroblasts.

Interleukin-17A Promotes Airway Remodeling in Chronic Obstructive Pulmonary Disease by Activating C-X-C Motif Chemokine Ligand 12 Secreted by Lung Fibroblasts.

Journal: Chronic obstructive pulmonary diseases (Miami, Fla.)

Published: July 16, 2024

Corynoxine suppresses lung adenocarcinoma proliferation and metastasis via inhibiting PI3K/AKT pathway and suppressing Cyclooxygenase-2 expression.

Corynoxine suppresses lung adenocarcinoma proliferation and metastasis via inhibiting PI3K/AKT pathway and suppressing Cyclooxygenase-2 expression.

Journal: Hereditas

Published: June 06, 2024

IL-17A-induced cancer-associated fibroblasts releases CXCL12 to promote lung adenocarcinoma progression via Wnt/β-Catenin signaling pathway.

IL-17A-induced cancer-associated fibroblasts releases CXCL12 to promote lung adenocarcinoma progression via Wnt/β-Catenin signaling pathway.

Journal: Cytokine

Published: April 11, 2024

Circular RNA circEZH2 Promotes Lung Adenocarcinoma Progression by Regulating microRNA-495-3p/Tumor Protein D52 Axis and Activating Nuclear Factor-Kappa B Pathway.

Circular RNA circEZH2 Promotes Lung Adenocarcinoma Progression by Regulating microRNA-495-3p/Tumor Protein D52 Axis and Activating Nuclear Factor-Kappa B Pathway.

Journal: International journal of general medicine

Published: April 10, 2024

Disulfidptosis-related lncRNAs signature predicting prognosis and immunotherapy effect in lung adenocarcinoma.

Disulfidptosis-related lncRNAs signature predicting prognosis and immunotherapy effect in lung adenocarcinoma.

Journal: Aging

Published: November 13, 2023

DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma.

DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 19, 2023

The Circular RNA circFOXK2 Enhances the Tumorigenesis of Non-Small Cell Lung Cancer Through the miR-149-3p/IL-6 Axis.

The Circular RNA circFOXK2 Enhances the Tumorigenesis of Non-Small Cell Lung Cancer Through the miR-149-3p/IL-6 Axis.

Journal: Biochemical genetics

Published: March 14, 2023

IL-17A activates mouse lung fibroblasts through promoting chemokine CXCL12 secretion

IL-17A activates mouse lung fibroblasts through promoting chemokine CXCL12 secretion

Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences

Published: January 15, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026